Last 12 months
Inside the activity.
6 purchase rows · 47 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 1 |
| Dec 2025 | 1 | 34 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2018 Filed Jul 11, 2018 17:05 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 596 | $2.48 | $1,478.08 |
DisclosureSEC source: 0000899243-18-019753 · doc4.xml · nonDerivative · entry 3 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 17:05 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 23,900 | $37.25 | $890,275.00 |
DisclosureSEC source: 0000899243-18-019753 · doc4.xml · nonDerivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $37.00 to $37.975 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 17:05 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 23,900 | $2.48 | $59,272.00 |
DisclosureSEC source: 0000899243-18-019753 · doc4.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| June 01, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 24,496 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · derivative · entry 6 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,068 Underlying: Ordinary Shares · 24,496 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| June 01, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 24,496 | $48.00 | $1,175,808.00 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · nonDerivative · entry 4 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| June 01, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 24,496 | $2.48 | $60,750.08 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · nonDerivative · entry 3 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 30, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 20,250 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · derivative · entry 9 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,778 Underlying: Ordinary Shares · 20,250 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014. Read SEC document |
| May 30, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 20,250 | $45.00 | $911,250.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 6 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,942 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 30, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 20,250 | $2.48 | $50,220.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 5 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 24,496 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · derivative · entry 5 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,564 Underlying: Ordinary Shares · 24,496 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 24,496 | $45.50 | $1,114,568.00 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · nonDerivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 18:29 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 24,496 | $2.48 | $60,750.08 |
DisclosureSEC source: 0000899243-18-014735 · doc4.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 29, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 3,145 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · derivative · entry 8 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,028 Underlying: Ordinary Shares · 3,145 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014. Read SEC document |
| May 29, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 3,145 | $45.00 | $141,525.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 4 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,942 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 29, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 3,145 | $2.48 | $7,799.60 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 3 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 25, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 8,316 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · derivative · entry 7 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,173 Underlying: Ordinary Shares · 8,316 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014. Read SEC document |
| May 25, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 8,316 | $45.00 | $374,220.00 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,942 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 25, 2018 Filed May 31, 2018 01:18 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 8,316 | $2.48 | $20,623.68 |
DisclosureSEC source: 0000899243-18-014497 · doc4.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 02, 2018 Filed May 5, 2018 00:04 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionShare Option (right to buy) · Derivative | 18,289 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-011575 · doc4.xml · derivative · entry 3 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,489 Underlying: Ordinary Shares · 18,289 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 422,778 ordinary shares that vest in thirty-six monthly installments beginning on December 12, 2014. Read SEC document |
| May 02, 2018 Filed May 5, 2018 00:04 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 18,289 | $45.00 | $823,005.00 |
DisclosureSEC source: 0000899243-18-011575 · doc4.xml · nonDerivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,942 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| May 02, 2018 Filed May 5, 2018 00:04 UTC |
BOLNO PAULDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 18,289 | $2.48 | $45,356.72 |
DisclosureSEC source: 0000899243-18-011575 · doc4.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 114 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · derivative · entry 8 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,060 Underlying: Ordinary Shares · 114 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F5 · derivative.exercise_date: The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 11,390 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · derivative · entry 7 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,390 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F4 · derivative.exercise_date: The share option represented a right to purchase a total of 20,802 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 11,504 | $55.95 | $643,648.80 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · nonDerivative · entry 5 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 11,504 | $2.48 | $28,529.92 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · nonDerivative · entry 4 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 16, 2018 Filed Feb 22, 2018 00:18 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 2,200 | $51.62 | $113,564.00 |
DisclosureSEC source: 0000899243-18-004953 · doc4.xml · nonDerivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,942 F1 · kind: On February 16, 2018, the reporting person sold 2,714 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan. F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.50 to $52.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed Feb 22, 2018 00:18 UTC |
BOLNO PAULDirector · President and CEO
|
SaleOrdinary Shares | 514 | $51.01 | $26,219.14 |
DisclosureSEC source: 0000899243-18-004953 · doc4.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,142 F1 · kind: On February 16, 2018, the reporting person sold 2,714 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $50.40 to $51.15 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 9,412 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · derivative · entry 6 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,390 Underlying: Ordinary Shares · 9,412 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F4 · derivative.exercise_date: The share option represented a right to purchase a total of 20,802 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 9,412 | $55.00 | $517,660.00 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · nonDerivative · entry 3 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
Exercise / conversionOrdinary Shares | 9,412 | $2.48 | $23,341.76 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · nonDerivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 19:19 UTC |
Francis ChrisSee Remarks
|
SaleOrdinary Shares | 723 | $51.80 | $37,451.40 |
DisclosureSEC source: 0000899243-18-004954 · doc4.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 F2 · kind: On February 16, 2018, the reporting person sold 723 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan. F3 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.55 to $51.95 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed Feb 22, 2018 00:16 UTC |
Regnante KeithChief Financial Officer
|
SaleOrdinary Shares | 316 | $51.85 | $16,384.60 |
DisclosureSEC source: 0000899243-18-004949 · doc4.xml · nonDerivative · entry 1 Regnante Keith · CIK 0001682068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,984 F1 · kind: On February 16, 2018, the reporting person sold 316 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.65 to $51.85 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 16, 2018 Filed Feb 22, 2018 00:17 UTC |
Panzara Michael A.Franchise Lead, Neurology
|
SaleOrdinary Shares | 511 | $52.10 | $26,623.10 |
DisclosureSEC source: 0000899243-18-004951 · doc4.xml · nonDerivative · entry 1 Panzara Michael A. · CIK 0001679039 · Franchise Lead, Neurology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,225 F1 · kind: On February 16, 2018, the reporting person sold 511 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.75 to $52.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 19:36 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-004668 · doc4.xml · derivative · entry 3 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,542 Underlying: Ordinary Shares · 2,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F2 · derivative.exercise_date: The incentive share option initially represented a right to purchase a total of 158,042 ordinary shares, 25% of which became exercisable on August 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 19:36 UTC |
Vargeese ChandraSee Remarks
|
SaleOrdinary Shares | 2,000 | $50.00 | $100,000.00 |
DisclosureSEC source: 0000899243-18-004668 · doc4.xml · nonDerivative · entry 2 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,300 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 19:36 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionOrdinary Shares | 2,000 | $2.48 | $4,960.00 |
DisclosureSEC source: 0000899243-18-004668 · doc4.xml · nonDerivative · entry 1 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:34 UTC |
Panzara Michael A.Franchise Lead, Neurology
|
Exercise / conversionShare Option (right to buy) · Derivative | 18,750 | $0.00 Strike: $21.69 | $0.00 |
DisclosureSEC source: 0000899243-18-004667 · doc4.xml · derivative · entry 3 Panzara Michael A. · CIK 0001679039 · Franchise Lead, Neurology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,250 Underlying: Ordinary Shares · 18,750 shares Expires 2026-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F2 · derivative.exercise_date: The share option represented a right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on July 11, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:34 UTC |
Panzara Michael A.Franchise Lead, Neurology
|
SaleOrdinary Shares | 18,750 | $50.00 | $937,500.00 |
DisclosureSEC source: 0000899243-18-004667 · doc4.xml · nonDerivative · entry 2 Panzara Michael A. · CIK 0001679039 · Franchise Lead, Neurology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,736 F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:34 UTC |
Panzara Michael A.Franchise Lead, Neurology
|
Exercise / conversionOrdinary Shares | 18,750 | $21.69 | $406,687.50 |
DisclosureSEC source: 0000899243-18-004667 · doc4.xml · nonDerivative · entry 1 Panzara Michael A. · CIK 0001679039 · Franchise Lead, Neurology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:12 UTC |
Vargeese ChandraSee Remarks
|
GrantShare Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002046 · doc4.xml · derivative · entry 5 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires 2028-01-23 F4 · derivative.exercise_date: The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:12 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionShare Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0000899243-18-002046 · doc4.xml · derivative · entry 4 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,542 Underlying: Ordinary Shares · 2,000 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. F2 · derivative.exercise_date: The incentive share option initially represented a right to purchase a total of 158,042 ordinary shares, 25% of which became exercisable on August 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:12 UTC |
Vargeese ChandraSee Remarks
|
GrantOrdinary Shares | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002046 · doc4.xml · nonDerivative · entry 3 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,300 F3 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:12 UTC |
Vargeese ChandraSee Remarks
|
SaleOrdinary Shares | 2,000 | $40.00 | $80,000.00 |
DisclosureSEC source: 0000899243-18-002046 · doc4.xml · nonDerivative · entry 2 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:12 UTC |
Vargeese ChandraSee Remarks
|
Exercise / conversionOrdinary Shares | 2,000 | $2.48 | $4,960.00 |
DisclosureSEC source: 0000899243-18-002046 · doc4.xml · nonDerivative · entry 1 Vargeese Chandra · CIK 0001657675 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:10 UTC |
Francis ChrisSee Remarks
|
GrantShare Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002045 · doc4.xml · derivative · entry 2 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2028-01-23 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 25, 2018 20:10 UTC |
Francis ChrisSee Remarks
|
GrantOrdinary Shares | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002045 · doc4.xml · nonDerivative · entry 1 Francis Chris · CIK 0001657709 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,800 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 26, 2018 01:05 UTC |
BOLNO PAULDirector · See Remarks
|
GrantShare Option (right to buy) · Derivative | 109,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002038 · doc4.xml · derivative · entry 2 BOLNO PAUL · CIK 0001657710 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,000 Underlying: Ordinary Shares · 109,000 shares Expires 2028-01-23 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25 of the shares quarterly thereafter until February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 26, 2018 01:05 UTC |
BOLNO PAULDirector · See Remarks
|
GrantOrdinary Shares | 54,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002038 · doc4.xml · nonDerivative · entry 1 BOLNO PAUL · CIK 0001657710 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,656 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 26, 2018 01:06 UTC |
Regnante KeithChief Financial Officer
|
GrantShare Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000899243-18-002040 · doc4.xml · derivative · entry 2 Regnante Keith · CIK 0001682068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Ordinary Shares · 26,000 shares Expires 2028-01-23 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022. Read SEC document |
| January 23, 2018 Filed Jan 26, 2018 01:06 UTC |
Regnante KeithChief Financial Officer
|
GrantOrdinary Shares | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-002040 · doc4.xml · nonDerivative · entry 1 Regnante Keith · CIK 0001682068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 F1 · shares: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.